William R. Shepard
At a glance: William R. Shepard is Director at CME Group (CME). Their latest SEC Form 4, filed Sep 28, 2026, reported a purchase of $79K. On file: 7 purchase lines ($667K) and 0 sale lines ($0).
Disclosed holdings: about $83.0M of CME stock: 266,909 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Sep 28, 2026), valued at the Nov 20, 2026 close of $311.15. This counts only CME shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Cme Group Inc. (CME)
Purchase track record
Market-like. Based on 3 purchases with a full 90 days of price history.
William R. Shepard's InsiderPrint
24 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Almost only buys, trading about 4 times a year, typically $62K a trade.
- Bump outward: a purchase (24)
- Dent inward: a sale (0)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Mark D. HoganDirector · BCBP · 100% matchTheir buys since 2020: 9 of 11 beat the S&P 500
- Glade M. KnightChair · APLE · 99% matchTheir buys since 2020: 11 of 20 beat the S&P 500
- Jeffrey A. GoldsteinDirector · FIS · 99% match
- Andrew M. CohnDirector · GWRS · 99% match
- Guy Archibald InnesDirector · VNRX · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2020
From the SEC's insider data sets: each open-market buy by William R. Shepard, matched to how the stock did over the next 90 days against the S&P 500.
9 of 19 buys beat the S&P 500 (47%), median -1.9% vs. the index. All insider buys: 46%.
| Stock | Filed | 90 days vs. S&P 500 |
|---|---|---|
| CME | Jun 29, 2026 | +17.2% |
| CME | Mar 30, 2026 | -41.0% |
| CME | Jan 2, 2026 | +19.6% |
| CME | Sep 26, 2025 | -1.9% |
| CME | Jun 26, 2025 | -11.0% |
| CME | Mar 27, 2025 | -2.6% |
| CME | Jan 17, 2025 | +25.0% |
| CME | Dec 30, 2024 | +19.1% |
| CME | Sep 27, 2024 | +4.5% |
| CME | Jun 26, 2024 | +7.3% |
| CME | Mar 27, 2024 | -13.9% |
| CME | Jan 19, 2024 | +0.4% |
Showing the latest 12 of 19.
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 28SEC | CMECme Group Inc.Off-schedule buyBefore earningsPast buys 9/19 beat S&P | Buy | 293263,289 held (+0%) | $268.76 | $79K | +15.8% |
| Jun 29SEC | CMECme Group Inc.Routine (Jun buyer)Before earningsPast buys 9/19 beat S&P | Buy | 143,621 held (+0%) | $230.57 | $3K | +34.9% |
| Jun 29SEC | CMECme Group Inc.Routine (Jun buyer)Before earningsPast buys 9/19 beat S&P | Buy | 325260,442 held (+0%) | $230.57 | $75K | +34.9% |
| Mar 30SEC | CMECme Group Inc.Routine (Mar buyer)Past buys 9/19 beat S&P | Buy | 1,408260,118 held (+1%) | $297.38 | $419K | +4.6% |
| Mar 30SEC | CMECme Group Inc.Routine (Mar buyer)Past buys 9/19 beat S&P | Buy | 622,539 held (+3%) | $297.38 | $18K | +4.6% |
| Jan 2SEC | CMECme Group Inc.Routine (Jan buyer)Before earningsPast buys 9/19 beat S&P | Buy | 112,477 held (+0%) | $278.37 | $3K | +11.8% |
| Jan 2SEC | CMECme Group Inc.Routine (Jan buyer)Before earningsPast buys 9/19 beat S&P | Buy | 251258,710 held (+0%) | $278.37 | $70K | +11.8% |
- Buy
Director William R Shepard bought $419K of CME at $297.38 — largest purchase by this insider in our records.
- Buy
Director William R Shepard bought $3K of CME at $278.37 — first open-market purchase in our records.
- Buy
Director William R Shepard bought $70K of CME at $278.37 — largest purchase by this insider in our records.
Follow William R. Shepard
Get one email when William R. Shepard files a new purchase or sale. Free.
At most one email a day about William R. Shepard, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.